Compare Cemex S.A.B. de C.V. Sponsored ADR (CX) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cemex S.A.B. de C.V. Sponsored ADR vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Cemex S.A.B. de C.V. Sponsored ADR trades at $9.56 (market cap $13.84B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: Cemex S.A.B. de C.V. Sponsored ADR is far larger — about 6.1× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Cemex S.A.B. de C.V. Sponsored ADR pays a 1.3% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| CX | SLS | |
|---|---|---|
Market Cap | $13.84B | $2.28B |
Volume | 6,589,714 | 3,128,960 |
Sector | Basic Materials | Health |
52-Week High | $13.55 | $15.46 |
52-Week Low | $9.12 | $1.39 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $19.83B | $2.15B |
Dividend Yield | 1.3% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Cemex S.A.B. de C.V. Sponsored ADR
Cemex produces, distributes, markets, and sells cement, ready-mix concrete, aggregates, and other construction materials. Its operations serve markets around the world.
Read more on CX →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
